UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients

The Journal of infectious diseases, 2007-09, Vol.196 (5), p.670-676

2007

Link zum Volltext

Verfügbarkeit prüfen

Update on HIV/HCV Coinfection

Current HIV/AIDS reports, 2013-09, Vol.10 (3), p.226-234

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2011-06, Vol.203 (11), p.1629-1636

2011

Link zum Volltext

Verfügbarkeit prüfen

Noncirrhotic portal hypertension in HIV infection

Current opinion in infectious diseases, 2011-02, Vol.24 (1), p.12-18

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B in HIV-Infected Patients

Clinics in liver disease, 2013-08, Vol.17 (3), p.489-501

2013

Link zum Volltext

Verfügbarkeit prüfen

Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients

Clinical infectious diseases, 2013-04, Vol.56 (8), p.1117-1122

2013

Link zum Volltext

Verfügbarkeit prüfen

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Antiviral therapy, 2013-01, Vol.18 (8), p.1033-1035

2013

Link zum Volltext

Verfügbarkeit prüfen

Viral hepatitis and HIV co-infection

Antiviral research, 2010, Vol.85 (1), p.303-315

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era

Infectious disease clinics of North America, 2012-12, Vol.26 (4), p.931-948

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

Clinical infectious diseases, 2014-06, Vol.58 (11), p.1549-1553

2014

Link zum Volltext

Verfügbarkeit prüfen

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

AIDS (London), 2009-03, Vol.23 (6), p.689-696

2009

Link zum Volltext

Verfügbarkeit prüfen

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

AIDS (London), 2010-05, Vol.24 (8), p.F23-F29

2010

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

Antiviral therapy, 2008, Vol.13 (1), p.103-107

2008

Link zum Volltext

Verfügbarkeit prüfen

Directly acting antivirals against hepatitis C virus

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1673-1686

2011

Link zum Volltext

Verfügbarkeit prüfen

Management and treatment of chronic hepatitis C in HIV patients

Seminars in liver disease, 2012-05, Vol.32 (2), p.138

2012

Link zum Volltext

Verfügbarkeit prüfen

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

AIDS (London), 2010-05, Vol.24 (8), p.1171-1176

2010

Link zum Volltext

Verfügbarkeit prüfen

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

AIDS (London), 2010-04, Vol.24 (7), p.1064-1066

2010

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Retrovirology, 2010-05, Vol.7 (S1), p.O13-O13, Article O13

2010

Link zum Volltext

Verfügbarkeit prüfen

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients

Retrovirology, 2010-05, Vol.7 (S1), p.P76-P76, Article P76

2010

Link zum Volltext

Verfügbarkeit prüfen

New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B

AIDS (London), 2011-04, Vol.25 (7), p.1013-1014

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

AIDS (London), 2011-01, Vol.25 (1), p.73-79

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of new oral hepatitis C antiviral drugs

Expert opinion on drug metabolism & toxicology, 2013-01, Vol.9 (1), p.5-16

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment failure with new hepatitis C drugs

Expert opinion on pharmacotherapy, 2012-02, Vol.13 (3), p.313-323

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis in the New IAS-USA Panel Antiretroviral Treatment Guidelines

AIDS reviews, 2010-09, Vol.12 (3)

Vispo, E

2010

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C therapy with HCV NS5B polymerase inhibitors

Expert opinion on pharmacotherapy, 2013-06, Vol.14 (9), p.1161-1170

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(110)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(94)
Life Sciences & Biomedicine
(87)
Science & Technology
(87)
Infectious Diseases
(82)
Male
(62)
Biological And Medical Sciences
(59)
Medical Sciences
(59)
Human Viral Diseases
(57)
Viral Diseases
(57)
Female
(56)
Hiv Infections - Drug Therapy
(55)
Adult
(53)
Human Immunodeficiency Virus
(53)
Immunology
(50)
Hiv
(49)
Hiv Infections - Complications
(49)
Virology
(48)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(44)
Middle Aged
(42)
Viral Hepatitis
(39)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients

Update on HIV/HCV Coinfection

Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients Receiving Antiretroviral Therapy

Noncirrhotic portal hypertension in HIV infection

Hepatitis B in HIV-Infected Patients

Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Viral hepatitis and HIV co-infection

Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

Directly acting antivirals against hepatitis C virus

Management and treatment of chronic hepatitis C in HIV patients

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients

New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B

Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

Pharmacokinetics of new oral hepatitis C antiviral drugs

Treatment failure with new hepatitis C drugs

Hepatitis in the New IAS-USA Panel Antiretroviral Treatment Guidelines

Hepatitis C therapy with HCV NS5B polymerase inhibitors

Suchergebnisse filtern